| Literature DB >> 16594996 |
Heinz G Endres1, Burkhard Dasch, Margitta Lungenhausen, Christoph Maier, Rüdiger Smektala, Hans J Trampisch, Ludger Pientka.
Abstract
BACKGROUND: Distal radius and proximal femoral fractures are typical injuries in later life, predominantly due to simple falls, but modulated by other relevant factors such as osteoporosis. Fracture incidence rates rise with age. Because of the growing proportion of elderly people in Western industrialized societies, the number of these fractures can be expected to increase further in the coming years, and with it the burden on healthcare resources. Our study therefore assessed the effects of these injuries on the health status of older people over time. The purpose of this paper is to describe the study method, clinical parameters of fracture patients during hospitalization, mortality up to one and a half years after discharge in relation to various factors such as type of fracture, and to describe changes in mobility and living situation.Entities:
Mesh:
Year: 2006 PMID: 16594996 PMCID: PMC1526725 DOI: 10.1186/1471-2458-6-87
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Study flow diagram.
Data for all 14,551 patients at time of admission by indication and type of hospital
| F: 9580 (76.5%) | F: 2975 (76.0%) | F: 6605 (76.7%) | F: 1658 (81.6%) | |
| M: 2940 (23.5%) | M: 939 (24.0%) | M: 2001 (23.3%) | M: 373 (18.4%) | |
| F: 79.1 (9.9) | Comparison acute-care versus rehabilitation facilities: | F: 69.4 (12.3) | ||
| M: 72.5 (12.9) | F: 81.3 (9.8) versus 78.1 (9.9) Δ = 3.2 years (p < 0.0001) | M: 59.4 (13.8) | ||
| (p < 0.0001) | M: 73.8 (13.3) versus 71.9 (12.6) Δ = 1.9 years (p < 0.0002) | (p < 0.0001) | ||
| < 25: 56.3% | Acute-care versus rehabilitation: < 25: 60.6% vs. 54.4% | < 25: 42.7% | ||
| 25–29.9: 32.6% | 25–29.9: 30.8% vs. 33.4% | 25–29.9: 42.2% | ||
| ≥ 30: 11.1% | ≥ 30: 8.6% vs. 12.2% | ≥ 30: 15.2% | ||
| (p < 0.0001) | ||||
| (I) 11.1% | Acute-care versus rehabilitation: (I): 5.3% vs. 13.6% | (I) 28.8% | ||
| (II) 46.7% | (II): 34.2% vs. 52.4% | (II) 51.4% | ||
| (III) 38.7% | (III): 55.2% vs. 31.3% | (III) 19.1% | ||
| (IV+V) 3.6% | (IV+V): 5.3% vs. 2.7% | (IV+V) 3.6% | ||
| (p < 0.0001) | ||||
| Proximal femur: 10,865 (86.8%) Distal femur: 138 (1.1%) Combination (usually with radius) or unclassified: 1,517 (12.1%) | Proximal femur: 3623 (92.6%) Distal femur: 27 (0.7%) Combination (usually with radius) or unclassified: 264 (6.7%) | Proximal femur: 7242 (84.2%) Distal femur: 111 (1.3%) Combination (usually with radius) or unclassified: 1253 (14.6%) | F: left arm 58.9%, right arm 39.6%, both arms 1.5% M: left arm 48.4%, right arm 50%, both arms 1.6% | |
| 4010 (32.0%) | 1170 (29.9%) | 2840 (33.0%) | 569 (28.0%) | |
| Radius: 11.2% | Radius: 10.4% | Radius: 11.6% | Radius: 12.6% | |
| Humerus: 4.5% | Humerus: 4.3% | Humerus: 4.7% | Humerus: 2.8% | |
| Vertebra: 4.4% | Vertebra: 3.7% | Vertebra: 4.7% | Vertebra: 2.6% | |
| Femur: 7.4% | Femur: 7.2% | Femur: 7.5% | Femur: 3.0% | |
| Other: 12.4% | Other: 11.2% | Other: 12.9% | Other: 11.8% | |
| 33.7% | 25.9% of 792 patients | 37.0% of 1889 patients | 23.4% of 590 patients | |
| Hypertension: 61.2% | Hypertension: 64.6% | Hypertension: 59.6% | Hypertension: 48.9% | |
| Diabetes: 20.5% | Diabetes: 22.6% | Diabetes: 19.5% | Diabetes: 11.3% | |
| CHD: 36.0% | CHD: 45.1% | CHD: 31.7% | CHD: 21.2% | |
| MI: 7.0% | MI: 7.6% | MI: 6.7% | MI: 3.2% | |
| PAD: 13.5% | PAD: 20.7% | PAD: 10.2% | PAD: 8.2% | |
| Stroke: 11.8% | Stroke: 14.0% | Stroke: 10.9% | Stroke: 4.8 | |
| Arthritis: 34.8% | Arthritis: 30.0% | Arthritis: 36.9% | Arthritis: 23.9% | |
| Rheumatism: 5.0% | Rheumatism: 5.4% | Rheumatism: 4.8% | Rheumatism: 3.6% | |
| COPD: 11.4% | COPD: 13.1% | COPD: 10.7% | COPD: 7.4% | |
| Malignant tumour: 10.1% | Malignant tumour: 10.0% | Malignant tumour: 10.2% | Malignant tumour: 5.9% | |
| Kidney dysfunction: 6.0% | Kidney dysfunction: 8.9% | Kidney dysfunction: 4.6% | Kidney dysfunction: 2.0% | |
ASA classification: I = normal healthy patient; II = patient with mild systemic disease; III = patient with severe systemic disease that is not incapacitating; IV = patient with incapacitating systemic disease that is a constant threat to life; V = moribund patient/CHD = Coronary Heart Disease/MI = Myocardial Infarction/PAD = Peripheral Arterial Disease/COPD = Chronic Obstructive Pulmonary Disease
Figure 2Age distribution of all 12,401 patients with femoral fracture at discharge.
Figure 3Age distribution of all 2,028 patients with distal forearm fracture at discharge.
Mortality data during hospital stay and post discharge
| 103 (2.6% of 3914) 85.3 years (± 8.2) | 16 (0.2% of 8606) 85.5 years (± 7.3) | 3 (0.15% of 2031) | |
| F: 72 (2.4% of 2975) 86.7 years (± 6.6) M: 31 (3.3% of 939) 81.9 years (± 10.4) | F: 10 (0.15% of 6605) 85.8 years (± 7.3) M: 6 (0.3% of 2001) 85.1 years (± 7.9) | F: 3 (0.2% of 1658) 81.3 years (± 6.6) | |
| p = 0.005 | p = 0.86 | ||
| 733 (19.2% of 3811) 83.9 years (± 8.7) | 730 (8.5% of 8590) 81.6 years (± 9.4) | 60 (3.0% of 2028) 80.4 years (± 9.9) | |
| F: 551 (19.0% of 2903) 85.0 years (± 8.0) M: 182 (20.0% of 908) 80.6 years (± 9.9) | F: 519 (7.9% of 6595) 83.0 years (± 8.6) M: 211 (10.6% of 1995) 78.1 years (± 10.3) | F: 54 (3.3% of 1655) 81.2 years (± 9.3) M: 6 (1.6% of 373) 73.7 years (± 13.1) | |
| p < 0.0001 | p < 0.0001 | p = 0.08 | |
| p = 0.08 | |||
Patients with pertrochanteric or cervical fracture who died in the first year post discharge: comparison of sex, age, ASA and BMI
| 335 (20.6% of 1624) | 290 (9.3% of 3106) | Chi square acute-care: p = 0.0007 Chi square rehabilitation: p = 0.0003 | |
| 281 (16.1% of 1744) | 273 (7.0% of 3918) | ||
| 473 (13.1% of 3603) | 152 (13.5% of 1127) | Chi square women: p < 0.0001 Chi square men: P = 0.477 | |
| 388 (9.0% of 4336) | 166 (12.5% of 1326) | ||
| 85.1 (± 7.9) | 78.6 (± 11.2) | t-Test women: p = 0.0006 t-Test men: p = 0.45 | |
| 83.2 (± 8.0) | 79.5 (± 9.4) | ||
| 2.8 (± 0.6) | 2.8 (± 0.7) | t-Test women: p = 0.005 t-Test men: p = 0.98 | |
| 2.7 (± 0.7) | 2.8 (± 0.7) | ||
| 23.2 (± 4.5) | 24.1 (± 4.0) | t-Test women: p = 0.26 t-Test men: p = 0.84 | |
| 23.6 (± 4.6) | 24.0 (± 3.8) | ||
Patients with femoral fracture: reported fracture location at discharge, two locations possible
| 1744 (45.8%) | 1321 (75.7%) | 3918 (45.6%) | 3015 (77.0%) | |
| 1624 (42.6%) | 1229 (75.7%) | 3106 (36.2%) | 2374 (76.4%) | |
| 160 (4.2%) | 119 (74.4%) | 205 (2.4%) | 155 (75.6%) | |
| 24 (0.6%) | 19 (79%) | 111 (1.3%) | 85 (76.6%) | |
| 12 (0.3%) | 8 (67%) | 21 (0.2%) | 16 (76%) | |
| 224 (5.9%) | 186 (83.0%) | 452 (5.3%) | 359 (79.4%) | |
| 23 (0.6%) | 21 (91%) | 777 (9.0%) | 591 (76.1%) | |
Femoral fracture patients: Reported operative procedure by fracture location at discharge
| OP yes (%) | 1673 (96.3%) | 1612 (99.4%) | 156 (97.5%) | 23 (95.8%) | 31 (88.6%) | 217 (96.9%) |
| OP no (%) | 65 (3.7%) | 10 (0.6%) | 4 (2.5%) | 1 (4.2%) | 4 (11.4%) | 7 (3.1%) |
| Missing (n) | 6 | 2 | 0 | 0 | 0 | 0 |
| OP yes (%) | 3355 (98.6%) | 2652 (99.7%) | 175 (100%) | 101 (98.1%) | 665 (97.2%) | 374 (90.8%) |
| OP no (%) | 46 (1.4%) | 8 (0.3%) | 0 | 2 (1.9%) | 19 (2.8%) | 38 (9.2%) |
| Missing (n) | 517 | 446 | 30 | 108 | 114 | 40 |
| 5028 (97.8%) | 4264 (99.6%) | 331 (98.8%) | 124 (97.6%) | 696 (96.8%) | 591 (92.9%) | |
| Nailing | 237 (4.7%) | 2833 (66.4%) | 251 (75.9%) | 57 (46.0%) | 246 (35.3%) | 227 (38.4%) |
| THP | 2046 (40.7%) | 105 (2.5%) | 17 (5.1%) | 11 (8.9%) | 191 (27.4%) | 105 (17.8%) |
| Screw or screws | 943 (18.8%) | 1280 (30.0%) | 63 (19.0%) | 19 (15.3%) | 146 (21.0%) | 137 (23.2%) |
| Intramedullary rod | 14 (0.3%) | 115 (2.7%) | 8 (2.4%) | 2 (1.6%) | 18 (2.6%) | 9 (1.5%) |
| Monopolar femoral head prosthesis | 204 (4.1%) | 12 (0.3%) | 1 (0.3%) | 2 (1.6%) | 12 (1.7%) | 13 (2.2%) |
| Bipolar femoral head prosthesis | 2011 (40.0%) | 72 (1.7%) | 8 (2.4%) | 2 (1.6%) | 150 (21.6%) | 111 (18.8%) |
| Other (incl. ligament suture) | 82 (1.6%) | 241 (5.7%) | 15 (4.5%) | 9 (7.3%) | 33 (4.7%) | 63 (10.7%) |
| K wire | 7 (0.1%) | 10 (0.2%) | 2 (0.6%) | 2 (1.6%) | 7 (1.0%) | 52 (8.8%) |
| Plate | 112 (2.2%) | 496 (11.6%) | 53 (16.0%) | 46 (37.1%) | 71 (10.2%) | 70 (11.8%) |
Patients at discharge and interview respondents: comparison of sex, age, and ASA
| 8,145 | 4,256 | 1,054 | 974 | |
| Acute F: 2279/M: 651 | Acute F: 624/M: 257 | Acute F: 871/M: 183 | Acute F: 784/M: 190 | |
| Rehab. F: 4074/M: 1141 | Rehab. F: 2521/M: 854 | |||
| F: 6353 (78.0%) | F: 3145 (73.9%) | F: 871 (82.6%) | F: 784 (80.5%) | |
| M: 1792 (22.0%) | M: 1111 (26.1%) | M: 183 (17.4%) | M: 190 (19.5%) | |
| p < 0.0001 | p = 0.21 | |||
| F: 80.6 (± 9.4) | F: 75.7 (± 10.2) | F: 72.1 (± 12.7) | F: 66.4 (± 11.0) | |
| M: 73.8 (± 13.0) | M: 70.2 (± 12.4) | M: 59.7 (± 15.7) | M: 59.1 (± 11.8) | |
| p < 0.0001 | p < 0.0001 | p < 0.0001 | p < 0.0001 | |
| F: Δ = -4.9 [-4.5 ; -5.3] | F: Δ = -5.7 [-4.6 ; -6.9] | |||
| M: Δ = -3.6 [-2.6 ; -4.6] | M: Δ = -0.6 [-3.5 ; +2.2] | |||
| F: 2.44 (± 0.69) | F: 2.15 (± 0.69) | F: 2.10 (± 0.68) | F: 1.80 (± 0.70) | |
| M: 2.44 (± 0.76) | M: 2.14 (± 0.79) | M: 1.78 (± 0.69) | M: 1.69 (± 0.72) | |
| p = 0.89 | p = 0.71 | p < 0.0001 | p = 0.056 | |
| F: Δ = -0.29 [-0.26 ; -0.32] | F: Δ = -0.30 [-0.24 ; -0.37] | |||
| M: Δ = -0.30 [-0.24 ; -0.36] | M: Δ = -0.09 [-0.24 ; +0.05] | |||